Pharmaceuticals & Biotech
Pharmaceutical manufacturers generate large volumes of wastewater contaminated with active pharmaceutical ingredients (APIs), solvents and other organics. Managing these streams is expensive, labor intensive and creates safety and logistical challenges. Axine can treat these streams on-site to reduce costs, risk, improve performance and ensure regulatory compliance. The Axine process mineralizes and destroys all types of APIs and other organic contaminants to meet the most stringent discharge requirements. For APIs, Axine can achieve treatment to below Predicted No-Effect Concentration (PNEC) levels.